H A Ghofrani Selected Research

H A Ghofrani Research Topics

Disease

34	Pulmonary Hypertension 03/2015 - 02/2000
21	Pulmonary Arterial Hypertension 04/2019 - 04/2002
6	Hypoxia (Hypoxemia) 03/2012 - 08/2000
5	Heart Failure 05/2012 - 03/2000
5	Familial Primary Pulmonary Hypertension 10/2008 - 01/2000
4	Vascular Remodeling 03/2012 - 06/2000
3	Disease Progression 04/2019 - 12/2001
3	Hypertension (High Blood Pressure) 12/2006 - 09/2006
2	Chronic Obstructive Pulmonary Disease (COPD) 05/2013 - 08/2009
2	Lung Diseases (Lung Disease) 04/2011 - 10/2010
2	Inflammation (Inflammations) 01/2011 - 04/2009
2	Hypotension (Low Blood Pressure) 10/2010 - 06/2000
2	Cardiomegaly (Heart Hypertrophy) 10/2008 - 03/2008
2	Thrombosis (Thrombus) 11/2002 - 06/2000
2	Fibrosis (Cirrhosis) 03/2000 - 03/2000
1	Epistaxis (Nosebleed) 04/2019
1	Hemorrhage 04/2019
1	Hereditary Hemorrhagic Telangiectasia 04/2019
1	Idiopathic Pulmonary Fibrosis 05/2013
1	Infarction (Infarctions) 01/2011
1	Infections 01/2011
1	Rupture 01/2011
1	Thromboembolism 11/2009
1	Arteriovenous Malformations (Arteriovenous Malformation) 11/2009
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2009
1	Hyperoxia 04/2009
1	Bronchopulmonary Dysplasia 04/2009
1	Autoimmune Hepatitis 09/2006
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 09/2006
1	Hepatitis 09/2006
1	HIV Infections (HIV Infection) 02/2004
1	Respiratory Insufficiency (Respiratory Failure) 08/2003
1	Vascular Diseases (Vascular Disease) 03/2000

Drug/Important Bio-Agent (IBA)

10	Iloprost (Ventavis)FDA Link 07/2009 - 01/2000
10	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2006 - 03/2000
9	ProstaglandinsIBA 04/2011 - 06/2000
7	Vasodilator Agents (Vasodilators)IBA 05/2012 - 03/2000
6	Endothelin Receptor AntagonistsIBA 04/2011 - 12/2006
6	Phosphodiesterase 5 InhibitorsIBA 04/2011 - 08/2001
6	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 08/2003 - 02/2000
5	riociguatIBA 03/2015 - 10/2008
5	Soluble Guanylyl CyclaseIBA 10/2010 - 08/2000
5	Sildenafil Citrate (Viagra)FDA Link 11/2007 - 11/2002
4	Oxygen (Dioxygen)IBA 08/2009 - 03/2000
4	Phosphodiesterase InhibitorsIBA 08/2009 - 11/2001
4	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 07/2008 - 08/2000
4	ThromboxanesIBA 11/2001 - 02/2000
3	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 04/2009 - 08/2003
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2009 - 01/2000
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 04/2019 - 12/2001
2	DiureticsIBA 05/2012 - 12/2001
2	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2012 - 04/2001
2	MonocrotalineIBA 05/2011 - 03/2008
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 04/2002 - 08/2000
2	AnticoagulantsIBA 12/2001 - 06/2000
2	Guanylate Cyclase (Guanylyl Cyclase)IBA 08/2001 - 08/2000
2	Superoxides (Superoxide)IBA 10/2000 - 08/2000
1	Activin Receptors (Activin Receptor)IBA 04/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2019
1	N 30IBA 05/2013
1	Clostridium perfringens epsilon-toxinIBA 05/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012
1	acetovanillone (apocynin)IBA 03/2012
1	Proteins (Proteins, Gene)FDA Link 03/2012
1	Small Interfering RNA (siRNA)IBA 03/2012
1	Serotonin (5 Hydroxytryptamine)IBA 05/2011
1	dironyl (terguride)IBA 05/2011
1	CytokinesIBA 01/2011
1	ChemokinesIBA 01/2011
1	rho-Associated KinasesIBA 10/2010
1	EndoglinIBA 11/2009
1	prednylidene (Pred)IBA 11/2009
1	Tyrosine Kinase InhibitorsIBA 08/2009
1	Endothelin-1 (Endothelin 1)IBA 06/2009
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 04/2009
1	Messenger RNA (mRNA)IBA 04/2009
1	pumafentrineIBA 03/2008
1	Endothelin Receptors (Endothelin Receptor)IBA 12/2006
1	Drug CombinationsIBA 12/2006
1	Pharmaceutical PreparationsIBA 12/2006
1	zardaverineIBA 08/2003
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 12/2001
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2001
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2001
1	Atrial Natriuretic Factor (ANF)IBA 10/2001
1	Dipyridamole (Persantine)FDA LinkGeneric 08/2001
1	Natriuretic PeptidesIBA 08/2001
1	UlaritideIBA 08/2001
1	diphenyleneiodoniumIBA 04/2001
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2000
1	6-anilino-5,8-quinolinedioneIBA 08/2000
1	Vasoconstrictor AgentsIBA 08/2000
1	Methylene Blue (Methylthioninium Chloride)FDA Link 08/2000
1	zaprinastIBA 08/2000
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2000

Therapy/Procedure

22	Therapeutics 09/2017 - 03/2000
3	Endarterectomy (Thromboendarterectomy) 05/2012 - 11/2007
1	Critical Care (Surgical Intensive Care) 05/2012
1	Septal Occluder Device 01/2011
1	Drug Tapering 10/2010